GPC3 and hepatocellular carcinoma: The incidences of high or low GPC-3 expression in HCC tissues were 45.5% (5 of 11) or 54.5% (6 of 11) at I staging, 52.6 % (10 of 19) or 47.4% (9 of 19) at II staging, 100% (39 of 39) or 0% (0 of 39) at III & IV staging, respectively.